10.3390/nu12092593 70
Monitoring and Adjusting Semaglutide Dosage In consultation with a healthcare provider, adjusting the dosage of semaglutide might be necessary
Review all co-administered medications to prevent interactions and ensure therapy continues safely until treatment goals are achieved
Abstract Semaglutide, a glucagon like peptide-1 (GLP-1) receptor agonist, is available as monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 receptor agonist)
The popularity of GLP-1 weight-loss medications continues to soarand their uptake is helping to push down obesity rates on a national scalebut a safe, evidence-based way off the drugs isnt yet in clear view
"Your explanations, when taken into consideration with the violations described above and your failure to adequately address your noncompliance, suggest systemic failures with your surveillance, receipt, evaluation, and reporting of ADEs to FDA," the agency wrote